| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/SLA.0B013E31822638F6 |
| P698 | PubMed publication ID | 21709543 |
| P50 | author | Valérie Boige | Q41786186 |
| Clarisse Dromain | Q51192569 | ||
| Frédéric Dumont | Q56950396 | ||
| P2093 | author name string | D Elias | |
| P Burtin | |||
| C Honoré | |||
| D Goéré | |||
| D Malka | |||
| M Ducreux | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 289-293 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | Annals of Surgery | Q4767866 |
| P1476 | title | Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis | |
| P478 | volume | 254 |
| Q55375912 | Adenocarcinoma of the Colon Disguised as Abdominal Wall Abscess: Case Report and Review of the Literature. |
| Q92618053 | Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients - study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study |
| Q34477640 | Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial |
| Q92323504 | Colorectal peritoneal metastases: Optimal management review |
| Q36758936 | Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal Cancer |
| Q36160064 | Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details |
| Q26768376 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection |
| Q49291015 | HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma |
| Q33418610 | Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis |
| Q39922489 | Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades |
| Q61182940 | Implementation of a Standardized HIPEC Protocol Improves Outcome for Peritoneal Malignancy |
| Q35110064 | Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients |
| Q90599804 | Individualized multimodal treatment strategy for metastatic rectal adenocarcinoma: Case report |
| Q35678364 | Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review |
| Q89999157 | LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer |
| Q54308984 | Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases. |
| Q26849259 | Looking up: Recent advances in understanding and treating peritoneal carcinomatosis |
| Q38219220 | Management of peritoneal carcinomatosis from colorectal cancer: review of the literature |
| Q37571642 | Multidisciplinary Treatment for Colorectal Peritoneal Metastases: Review of the Literature |
| Q90618560 | Overall risk and risk factors for metachronous peritoneal metastasis after colorectal cancer surgery: a nationwide cohort study |
| Q55605577 | Oxaliplatin-induced bronchiolitis obliterans organizing pneumonia following hyperthermic intraperitoneal chemotherapy. |
| Q97894912 | PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases |
| Q36646562 | Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomy |
| Q91676659 | Perceptions in the management of colorectal peritoneal metastases: A bi-national survey of colorectal surgeons |
| Q34366940 | Peritoneal carcinomatosis of gastrointestinal tumors: where are we now? |
| Q38260693 | Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview |
| Q47166165 | Principles and Innovations in Peritoneal Surface Malignancy Treatment |
| Q36758901 | Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). |
| Q101353613 | Results from the PROPHYLOCHIP-PRODIGE 15 trial |
| Q101353630 | Results from the PROPHYLOCHIP-PRODIGE 15 trial - Authors' reply |
| Q55424667 | Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer. |
| Q38555902 | Role of aggressive surgery for peritoneal metastases |
| Q50099096 | Safety and efficacy of combined resection of colorectal peritoneal and liver metastases |
| Q53093164 | Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC). |
| Q42324105 | Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives? |
| Q97894909 | Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study |
| Q92716708 | Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer |
| Q97525347 | Surgical management and hyperthermic intraperitoneal chemotherapy for locally advanced colorectal cancer |
| Q97525355 | Surgical management of recurrent colon cancer |
| Q41994931 | Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report |
| Q26768405 | Surgical technology and pharmacology of hyperthermic perioperative chemotherapy |
| Q38163913 | Surgical treatment of peritoneal carcinomatosis: current treatment modalities |
| Q38780368 | Surveillance after curative treatment for colorectal cancer |
| Q26783662 | Treatment of peritoneal metastases from colorectal cancer |
| Q26744031 | Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives |
| Q57162967 | [Surgical treatment of peritoneal metastases of colorectal cancer] |
Search more.